Routine molecular diagnostic laboratories can benefit from using GA’s products by choosing one of two options:
- Use of GA map® reagent kit: The routine diagnostic laboratory can implement the GA-map® Technology platform and established the GA-map® Test. Fecal samples are locally collected and analyzed by the laboratory. GA will continuously provide CE-marked and validated reagents kit.
- Use of GA service laboratory: Fecal samples are locally collected, assembled by the routine diagnostic laboratory, and regularly send batchwise for analysis and reporting to Genetic Analysis service laboratory, Oslo Norway. Encrypted reports are sent back to the routine diagnostic laboratory.
The two products GA provides are The GA-map® Dysbiosis Test and The GA-map® COVID-19 Fecal Test. The two tests can be set up in any PCR laboratory and GA provides reagent kit for own use or we do the analysis and reporting of the result at our service laboratory
The GA-map® Dysbiosis Test Lx
Genetic Analysis has developed a CE-marked probe based gut microbiota test on the Luminex® 200 instrument. The technology takes advantage of nucleotide differences in the bacterial 16S rRNA gene to identify predetermined targets.
The GA-map® COVID-19 Fecal Test
The GA-map® COVID-19 Fecal Test is a Qualitative Real Time standardized PCR test for the detection of the 2019 novel coronavirus (SARS-CoV-2) RNA in stool samples and is validated and CE-marked.
The GA-map® Dysbiosis Test Lx reagent kit
The reagent kit is produced in our ISO 13485 certified facilities in Oslo, Norway. Included in the product is a software that performs QC on the run file, calculates the dysbiosis index (DI) score and Abundance table and converts each sample result into an easy-to-understand result report.